APA (7th ed.) Citation

Hu, M., Robinson, O., Lill, C. M., Matton, A., Puerta, R., Sanz, P., . . . Middleton, L. (2026). Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation. Annals of Clinical & Translational Neurology, 13(2), 354. https://doi.org/10.1002/acn3.70227

Chicago Style (17th ed.) Citation

Hu, Manyue, Oliver Robinson, Christina M. Lill, Anna Matton, Raquel Puerta, Pilar Sanz, Merce Boada, Agustín Ruiz, and Lefkos Middleton. "Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation." Annals of Clinical & Translational Neurology 13, no. 2 (2026): 354. https://doi.org/10.1002/acn3.70227.

MLA (9th ed.) Citation

Hu, Manyue, et al. "Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation." Annals of Clinical & Translational Neurology, vol. 13, no. 2, 2026, p. 354, https://doi.org/10.1002/acn3.70227.